Literature DB >> 15458777

The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores.

Christopher K Cote1, Kelly M Rea, Sarah L Norris, Nico van Rooijen, Susan L Welkos.   

Abstract

The pathogenesis of infection by Bacillus anthracis has been the subject of many investigations, but remains incompletely understood. It has been shown that B. anthracis spores germinate in macrophages and perhaps require this intracellular niche to germinate in vivo before outgrowth of the vegetative organism. However, it has also been reported that macrophages are sporicidal in vitro. In our in vivo model, macrophages were depleted from mice by either silica treatment or treatment with liposome-encapsulated dichloromethylene disphosphonate (Cl(2)MDP), and the animals were infected parenterally with virulent ungerminated B. anthracis (Ames strain) spores. The mice in which macrophages had been depleted were killed more rapidly than untreated mice. In addition, augmenting peritoneal populations of macrophages with cultured RAW264.7 cells partially protected mice from disease, increasing the survival rate in a dose dependent relationship. Alveolar macrophages were depleted by intranasal instillation of liposome-encapsulated Cl(2)MDP. The animals with normal alveolar macrophage numbers had significantly greater survival rates after inhaling B. anthracis spores than the macrophage-depleted mice. These findings do not preclude the observations that macrophages provide a site permissive for spore germination, however, these data suggest that macrophages do play an important role in limiting and/or clearing a B. anthracis infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458777     DOI: 10.1016/j.micpath.2004.06.013

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  32 in total

1.  What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax?

Authors:  Jean-Nicolas Tournier; Aurélie Cleret; Anne Quesnel-Hellmann
Journal:  Infect Immun       Date:  2009-01       Impact factor: 3.441

2.  Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.

Authors:  Christopher K Cote; Nico Van Rooijen; Susan L Welkos
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  The Secretory Leukocyte Protease Inhibitor mRNA expression is involved with inflammatory control after downhill exercise in the triceps brachii intermediary head in Wistar rats.

Authors:  André Luis Araujo Minari; Lila Missae Oyama; Ronaldo Vagner Thomatieli Dos Santos
Journal:  J Muscle Res Cell Motil       Date:  2017-06-30       Impact factor: 2.698

5.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

6.  Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress.

Authors:  Robert J Cybulski; Patrick Sanz; Farhang Alem; Scott Stibitz; Robert L Bull; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

7.  The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene.

Authors:  Zhiyu Li; John Fallon; John Mandeli; James Wetmur; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

8.  A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.

Authors:  Zhiyu Li; John Fallon; John Mandeli; James Wetmur; Savio L C Woo
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

9.  Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b.

Authors:  Jill K Terra; Christopher K Cote; Bryan France; Amy L Jenkins; Joel A Bozue; Susan L Welkos; Steven M LeVine; Kenneth A Bradley
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice.

Authors:  Christer Larsson; Jenny Lundqvist; Nico van Rooijen; Sven Bergström
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.